目錄:MedChemExpress LLC>>生化試劑>> Neoseptin 3 | MCE
參考價(jià) | ¥ 3040 |
參考價(jià) | ¥ 3040 |
更新時(shí)間:2023-06-28 09:26:54瀏覽次數(shù):156評(píng)價(jià)
聯(lián)系我們時(shí)請(qǐng)說(shuō)明是化工儀器網(wǎng)上看到的信息,,謝謝!
CAS | 1622863-21-1 | 純度 | 99.57% |
---|---|---|---|
分子量 | 474.59 | 分子式 | C??H??N?O? |
供貨周期 | 現(xiàn)貨 | 規(guī)格 | 5 mg |
貨號(hào) | HY-U00435 | 應(yīng)用領(lǐng)域 | 醫(yī)療衛(wèi)生,化工,生物產(chǎn)業(yè),制藥 |
MCE 的所有產(chǎn)品僅用作科學(xué)研究或藥證申報(bào),,我們不為任何個(gè)人用途提供產(chǎn)品和服務(wù)。
CAS No. : 1622863-21-1
產(chǎn)品活性:Neoseptin 3 is a Toll-like receptor 4/myeloid differentiation factor 2 (mTLR4/MD-2) agonist with an EC50 of 18.5 μM.
研究領(lǐng)域:Immunology/Inflammation
作用靶點(diǎn):Toll-like Receptor (TLR)
In Vitro: Neoseptin 3 is a Toll-like receptor 4/myeloid differentiation factor 2 (mTLR4/MD-2) agonist with an EC50 of 18.5 μM. Neoseptin-3 induces TNFα production by macrophages in a concentration-dependent manner. Neoseptin-3 induces phosphorylation of IκB kinases α (IKKα), IKKβ, p38, c-Jun N-terminal kinase (JNK), and ERK, and degradation of IκBα, consistent with activation of MAPK and canonical NF-κB signaling. TANK-binding kinase 1 (TBK1) and IRF3 phosphorylation also increase in response to Neoseptin-3.
相關(guān)產(chǎn)品:Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Anti-Cancer Compound Library | Small Molecule Immuno-Oncology Compound Library | Antioxidant Compound Library | Reprogramming Compound Library | Oxygen Sensing Compound Library | Pyroptosis Compound Library | Targeted Diversity Library | Pain-Related Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | C29 | ODN 1018 | TLR7 agonist 5 | AN-3485 | ODN 2088 | TLR4/NF-κB/MAPK-IN-1 | TLR9-IN-1 | ODN 105871 | MC-Val-Cit-PAB-Amide-TLR7 agonist 4 | Monophosphoryl lipid A | β-D-Glucan | Poly (I:C):Kanamycin (1:1) (sodium) | ODN TTAGGG | Bropirimine | Polygalasaponin F | Chloroquine-d5 (diphosphate) | DB-3-291 | ODN 24888 | ODN 2216 | Agatolimod | Enpatoran hydrochloride | BBIQ | UC-1V150 | AZD8848 | ODN 105870 | CU-T12-9 | TLR7/8 agonist 7 | ODN 21158 | TH1020 | Lefitolimod
熱門(mén)產(chǎn)品線(xiàn):重組蛋白 | 化合物庫(kù) | 天然產(chǎn)物 | 熒光染料 | PROTAC | 同位素標(biāo)記物 | 寡核苷酸 | 抗體 | 點(diǎn)擊化學(xué)
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides | Antibodies | Click Chemistry
品牌介紹:
• MCE (MedChemExpress) 擁有200 多種*僅有化合物庫(kù),我們致力于為*科研客戶(hù)提供前沿的高品質(zhì)小分子活性化合物,;
• 50,000 多種高選擇性抑制劑、激動(dòng)劑涉及各熱門(mén)信號(hào)通路及疾病領(lǐng);
• 產(chǎn)品種類(lèi)涵蓋各種重組蛋白,多肽,,常用試劑盒 ,更有 PROTAC,、ADC 等特色產(chǎn)品,,廣泛應(yīng)用于新藥研發(fā)、生命科學(xué)等科研項(xiàng)目,;
• 提供虛擬篩選,,離子通道篩選,,代謝組學(xué)分析檢測(cè)分析,藥物篩選等專(zhuān)業(yè)技術(shù)服務(wù),;
• 設(shè)有專(zhuān)業(yè)的實(shí)驗(yàn)中心和嚴(yán)格的質(zhì)控,、驗(yàn)證體系;
• 提供 LC/MS,、NMR,、HPLC、手性分析,、元素分析等各項(xiàng)質(zhì)檢報(bào)告,,確保產(chǎn)品的高純度,、高品質(zhì),;
• 產(chǎn)品的生物活性多經(jīng)各國(guó)客戶(hù)實(shí)驗(yàn)驗(yàn)證;
• Nature, Cell, Science 等多種頂級(jí)期刊及制藥 Patent 收錄了MCE客戶(hù)的科研成果,;
• 專(zhuān)業(yè)團(tuán)隊(duì)跟蹤最新的制藥及生命科學(xué)研究進(jìn)展,,為您提供*新的活性化合物;
• 與世界各大制藥公司及著名科研機(jī)構(gòu)建立了長(zhǎng)期的合作,。
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)